Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

In this analysis, researchers aimed to evaluate the clinicopathologic characteristics, metastatic patterns, and survival outcomes in patients with metastatic prostate cancer and low-volume primary ...

Academics from the University of Bedfordshire have worked with other experts on new research into prostate cancer ...

Academics from the University of Bedfordshire have worked with other experts on new research into prostate cancer ...

The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...

The Urology Care Foundation and the Prostate Cancer Foundation have created a new educational guide on genetic tests to guide ...

Mayo Clinic researchers have developed and evaluated MedEduChat, an electronic health record (EHR) that works with a large ...

A large-scale study has identified dozens of blood proteins linked to prostate cancer risk, some shared across populations, ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...

The SHARON trial combines chemotherapy, vitamins, and stem cells to treat advanced pancreatic cancer with BRCA or PALB2 mutations, showing promising early results. This precision medicine approach ...